https://www.pharmaceutical-technology.com/ The leading site for news and procurement in the pharmaceutical industry Wed, 17 Apr 2024 16:04:04 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png https://www.pharmaceutical-technology.com/ 32 32 https://www.pharmaceutical-technology.com/news/igm-and-sanofi-collaboration-will-pivot-to-immunology-and-inflammation/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_1536904274.jpg Wed, 17 Apr 2024 16:04:01 +0000 https://www.pharmaceutical-technology.com/news/igm-and-sanofi-collaboration-will-pivot-to-immunology-and-inflammation/ https://www.pharmaceutical-technology.com/news/lexeo-wins-fast-track-designation-for-friedreichs-ataxia-gene-therapy/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2197321013-e1713366035493.jpg Wed, 17 Apr 2024 15:17:56 +0000 https://www.pharmaceutical-technology.com/news/lexeo-wins-fast-track-designation-for-friedreichs-ataxia-gene-therapy/ https://www.pharmaceutical-technology.com/data-insights/eagle-pharmaceuticals-gets-grant-for-long-term-stable-bendamustine-containing-composition-in-sterile-vial-2/ https://www.pharmaceutical-technology.com/data-insights/eagle-pharmaceuticals-gets-grant-for-long-term-stable-bendamustine-containing-composition-in-sterile-vial-2/#respond Wed, 17 Apr 2024 12:36:23 +0000 https://www.pharmaceutical-technology.com/data-insights/eagle-pharmaceuticals-gets-grant-for-long-term-stable-bendamustine-containing-composition-in-sterile-vial-2/feed/ 0 https://www.pharmaceutical-technology.com/data-insights/beyondspring-gets-grant-for-treating-cancer-expressing-mutant-ras-protein-with-plinabulin/ https://www.pharmaceutical-technology.com/data-insights/beyondspring-gets-grant-for-treating-cancer-expressing-mutant-ras-protein-with-plinabulin/#respond Wed, 17 Apr 2024 12:36:20 +0000 https://www.pharmaceutical-technology.com/data-insights/beyondspring-gets-grant-for-treating-cancer-expressing-mutant-ras-protein-with-plinabulin/feed/ 0 https://www.pharmaceutical-technology.com/data-insights/gritstone-bio-gets-grant-for-method-of-identifying-cassette-sequence-for-neoantigen-vaccine/ https://www.pharmaceutical-technology.com/data-insights/gritstone-bio-gets-grant-for-method-of-identifying-cassette-sequence-for-neoantigen-vaccine/#respond Wed, 17 Apr 2024 12:36:18 +0000 https://www.pharmaceutical-technology.com/data-insights/gritstone-bio-gets-grant-for-method-of-identifying-cassette-sequence-for-neoantigen-vaccine/feed/ 0 https://www.pharmaceutical-technology.com/data-insights/decibel-therapeutics-gets-grant-for-hypertonic-pharmaceutical-composition-for-anti-platinum-chemoprotection-2/ https://www.pharmaceutical-technology.com/data-insights/decibel-therapeutics-gets-grant-for-hypertonic-pharmaceutical-composition-for-anti-platinum-chemoprotection-2/#respond Wed, 17 Apr 2024 12:36:16 +0000 https://www.pharmaceutical-technology.com/data-insights/decibel-therapeutics-gets-grant-for-hypertonic-pharmaceutical-composition-for-anti-platinum-chemoprotection-2/feed/ 0 https://www.pharmaceutical-technology.com/data-insights/corvus-pharmaceuticals-gets-grant-for-modulating-interleukin-2-inducible-t-cell-kinase/ https://www.pharmaceutical-technology.com/data-insights/corvus-pharmaceuticals-gets-grant-for-modulating-interleukin-2-inducible-t-cell-kinase/#respond Wed, 17 Apr 2024 12:36:13 +0000 https://www.pharmaceutical-technology.com/data-insights/corvus-pharmaceuticals-gets-grant-for-modulating-interleukin-2-inducible-t-cell-kinase/feed/ 0 https://www.pharmaceutical-technology.com/data-insights/oric-pharmaceuticals-gets-grant-for-plk4-inhibitors-for-treating-cancer/ https://www.pharmaceutical-technology.com/data-insights/oric-pharmaceuticals-gets-grant-for-plk4-inhibitors-for-treating-cancer/#respond Wed, 17 Apr 2024 12:36:11 +0000 https://www.pharmaceutical-technology.com/data-insights/oric-pharmaceuticals-gets-grant-for-plk4-inhibitors-for-treating-cancer/feed/ 0 https://www.pharmaceutical-technology.com/data-insights/unity-biotechnology-gets-grant-for-senolytic-agents-for-treating-age-related-eye-conditions/ https://www.pharmaceutical-technology.com/data-insights/unity-biotechnology-gets-grant-for-senolytic-agents-for-treating-age-related-eye-conditions/#respond Wed, 17 Apr 2024 12:36:09 +0000 https://www.pharmaceutical-technology.com/data-insights/unity-biotechnology-gets-grant-for-senolytic-agents-for-treating-age-related-eye-conditions/feed/ 0 https://www.pharmaceutical-technology.com/data-insights/kaleido-biosciences-gets-grant-for-glycan-therapeutic-preparation-for-reducing-gastrointestinal-inflammation-in-immune-imbalance/ https://www.pharmaceutical-technology.com/data-insights/kaleido-biosciences-gets-grant-for-glycan-therapeutic-preparation-for-reducing-gastrointestinal-inflammation-in-immune-imbalance/#respond Wed, 17 Apr 2024 12:36:07 +0000 https://www.pharmaceutical-technology.com/data-insights/kaleido-biosciences-gets-grant-for-glycan-therapeutic-preparation-for-reducing-gastrointestinal-inflammation-in-immune-imbalance/feed/ 0